Description
FARMINGDALE, NY — Codagenix Inc., a Farmingdale-based biotech company, recently saw its coronavirus vaccine candidate begin production by a global vaccine manufacturer, Newsday reported. The potential vaccine has not yet begun its Phase 1 human clinical trials in the United Kingdom, but those are expected to be underway by the end of the year, according to Newsday.
Read the full Newsday story here.
Discussion
By posting you agree to the Terms and Privacy Policy.